title: Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome.
authors.forename: Koki
authors.initials: K
authors.lastname: Ueda
authors.forename: Sumimasa
authors.initials: S
authors.lastname: Nagai
authors.forename: Shin-ich
authors.initials: SI
authors.lastname: Miyashita
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Kaise
authors.forename: Motoshi
authors.initials: M
authors.lastname: Ichikawa
authors.forename: Keiki
authors.initials: K
authors.lastname: Kumano
authors.forename: Akira
authors.initials: A
authors.lastname: Hangaishi
authors.forename: Yasuhito
authors.initials: Y
authors.lastname: Nannya
authors.forename: Mineo
authors.initials: M
authors.lastname: Kurokawa
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010087:Oxides / Q000009:adverse effects / Q000627:therapeutic use*; D010490:Pericardial Effusion / Q000139:chemically induced*; D010996:Pleural Effusion / Q000139:chemically induced*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide